ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 3.32% of MBRX shares are held by financial institutions. ARMISTICE CAPITAL, LLC is the top corporate investor, holding 3.21M shares valued at $2.75M. A 10.76% stake in Moleculin Biotech, Inc. is owned by the company. VANGUARD GROUP INC owns 1.08M shares valued at $927.18K, which translates its holding of 3.62% of the stake in the company.
Among the MBRX insiders holding of 0.72% of the stake in company, CREDIT SUISSE/, 10 percent owner, holds the largest shares of 3.86M. PRIEBE WALDEMAR, 10 percent owner, is the second largest MBRX insider with ownership of 2.78M shares. KLEMP WALTER V, CEO and President, stands third with possession of 680.88K shares of that stake.